Home | Welcome to Contract Pharma   
Last Updated Thursday, May 28 2015

Print

Search Results for 'Financial Report: AMRI'

Search For:
Refine by Dates:
From: To:
Past 7 Days        Past 30 Days
Refine By Content:

Search Results:

Published May 5, 2015
Contract revenue up 47% in the quarter Read More »
Published February 12, 2015
Contract revenue up 35% in the quarter Read More »
Published November 7, 2014
Contract revenue up 8% in the quarter Read More »
Published August 5, 2014
Cedarburg business boosts large scale manufacturing revenue Read More »
Published May 6, 2014
Decline in royalties impacts results Read More »
By Kristin Brooks
Published February 12, 2014
Achieves record contract revenues Read More »
Published November 6, 2013
Contract revenue up 16% in the quarter Read More »
Published August 6, 2013
Revenues up 19% in the quarter Read More »
Published May 7, 2013
Revenues up 11% in the quarter Read More »
Published February 12, 2013
Unaudited revenues up 44% in the quarter Read More »
Published November 6, 2012
Large-scale manufacturing revenue up 14% Read More »
Published August 1, 2012
Contract revenue down 3% in the quarter Read More »
By Gil Roth
Published May 9, 2012
Hungary closure leads to charges Read More »
Published November 8, 2011
Achieves 17% growth in large-scale manufacturing, exits internal pharma R&D Read More »
Published November 9, 2010
Total contract revenue for the quarter was $42.9 million (+8%). Read More »
Published May 5, 2010
Total contract revenue for the quarter was $38.9 million (-10%). Read More »
Published February 9, 2009
Contract revenue for the quarter, which includes Discovery Services, Development and Small Scale Manufacturing, and Large Scale Manufacturing, was $49.6 million (+22%) and $195.5 million for the year (+20%). Read More »
Published November 7, 2008
AMRI 3Q Revenues: $61.4 million (+29%) 3Q Earnings: $7.0 million (+250%) YTD Revenues: $172.9 million (+19%) YTD Earnings: $17.4 million (+78%) Comments: Total contract revenue for the quarter was $54.1 million (+30%). Discovery Servi… Read More »
Published May 5, 2008
AMRI 1Q Revenues: $53.6 million (+11%) 1Q Earnings: $4.7 million (+47%) Comments: Total contract revenue increased to $45.3 million in the quarter (+10%).  Discovery Services revenue was $13.3 million (+34%). Development and Small Scale… Read More »
Published February 11, 2008
AMRI 4Q Revenues: $47.2 million (+1%) 4Q Loss: $844,000 (loss of $764,000 in 4Q2006) FY Revenues: $192.5 million (+7%) FY Earnings: $8.9 million (earnings were $2.2 million FY2006) Comments: Total contract and milestone revenue for th… Read More »
Published August 2, 2007
AMRI 2Q Revenues: $49.4 million (+8%) 2Q Earnings: $4.6 million (loss of $353,000 in 2Q2006)* YTD Revenues: $97.7 million (+10%) YTD Earnings: $7.8 million (earnings were $1.5 million YTD2006) Comments: Contract revenue in the q… Read More »
Published May 4, 2007
AMRI 1Q Revenues: $48.4 million (+12%) 1Q Earnings: $3.2 million (+70%) Comments: Total contract revenue in the quarter was $41.2 million, up 14%. Revenue from Discovery Services was $9.9 million, up 21%. Development and Small Scale Manufa… Read More »
Published November 9, 2006
AMRI 3Q Revenues: $44.2 million (flat) 3Q Earnings: $1.4 million (-68%) YTD Revenues: $133.2 million (-8%) YTD Earnings: $2.9 million (-83%) Comments: Total contract revenue for the quarter was $37.9 million, up 20%. Contract reve… Read More »
Published August 2, 2006
AMRI 2Q Revenues: $45.6 million (-12%) 2Q Loss: $353,000* (earnings were $7.3 million in 2Q2005) YTD Revenues: $88.9 million (-12%) YTD Earnings: $1.5 million (earnings were $12.9 million YTD2005) Comments: Revenue for Discover… Read More »


Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On